DC4.F DexCom Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
71.80 EUR
Close of Nov 12, 2026
48.50 79.60
Market cap
EUR 26.8B
P/E
33.2x
P/B
11.82x
ROE
38.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DC4.F undervalued?

Graham number

The Graham number of DexCom Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DexCom Inc fundamental analysis

No fundamental analysis for DexCom Inc yet.

DexCom Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed …

Full company profile